Biologics Market Size, Top Share, Global Trends And Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Biologics Market Size Analysis

Global Biologics Market Introduction
By Source
1. Introduction
  1. Source By Value
2. Microbial
  1. By Value
3. Mammalian
  1. By Value
4. Others
  1. By Value
By Manufacturing
1. Introduction
  1. Manufacturing By Value
2. In-house
  1. By Value
3. Outsourced
  1. By Value
By Product
1. Introduction
  1. Product By Value
2. Monoclonal Antibodies
  1. By Value
3. Vaccines
  1. By Value
4. Recombinant Proteins
  1. By Value
5. Antisense & RNAi Therapeutics
  1. By Value
6. Others
  1. By Value
By Disease Category
1. Introduction
  1. Disease Category By Value
2. Oncology
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorders
  1. By Value
5. Cardiovascular Disorders
  1. By Value
6. Hematological Disorders
  1. By Value
7. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tumor Necrosis Factor (TNF) Inhibitor
  1. By Value
3. T-cell Inhibitor
  1. By Value
4. Selective Co-stimulation Modulators
  1. By Value
5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
  1. By Value
6. Interleukin-1 (IL-1) Blocker
  1. By Value
7. B-cell Inhibitor
  1. By Value
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Monoclonal Antibody
  1. By Value
3. Recombinant Insulin
  1. By Value
4. Vaccine
  1. By Value
5. Blood Factor
  1. By Value
6. Human Growth Hormone
  1. By Value
7. Erythropoietin
  1. By Value
8. Fusion Protein
  1. By Value
9. Recombinant Enzyme
  1. By Value
10. Interferon
  1. By Value
11. Colony-stimulating Factor
  1. By Value
12. Gene Therapy
  1. By Value
13. Cell Therapy
  1. By Value
14. Oligonucleotides
  1. By Value
15. Peptide
  1. By Value
16. Botulinum Toxin
  1. By Value
17. Others
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Branded Drugs
  1. By Value
3. Generic Drugs
  1. By Value
By Mode of Purchase
1. Introduction
  1. Mode of Purchase By Value
2. Prescription Drugs
  1. By Value
3. Over-the-counter (OTC) Drugs
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injection
  1. By Value
3. Tablets
  1. By Value
4. Others
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Parenteral
  1. By Value
3. Oral
  1. By Value
4. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals
  1. By Value
3. Specialty Clinics
  1. By Value
4. Homecare
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacy
  1. By Value
3. Retail Pharmacy
  1. By Value
4. Online Pharmacy
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Source
1. Introduction
  1. Source By Value
2. Microbial
  1. By Value
3. Mammalian
  1. By Value
4. Others
  1. By Value
By Manufacturing
1. Introduction
  1. Manufacturing By Value
2. In-house
  1. By Value
3. Outsourced
  1. By Value
By Product
1. Introduction
  1. Product By Value
2. Monoclonal Antibodies
  1. By Value
3. Vaccines
  1. By Value
4. Recombinant Proteins
  1. By Value
5. Antisense & RNAi Therapeutics
  1. By Value
6. Others
  1. By Value
By Disease Category
1. Introduction
  1. Disease Category By Value
2. Oncology
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorders
  1. By Value
5. Cardiovascular Disorders
  1. By Value
6. Hematological Disorders
  1. By Value
7. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tumor Necrosis Factor (TNF) Inhibitor
  1. By Value
3. T-cell Inhibitor
  1. By Value
4. Selective Co-stimulation Modulators
  1. By Value
5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
  1. By Value
6. Interleukin-1 (IL-1) Blocker
  1. By Value
7. B-cell Inhibitor
  1. By Value
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Monoclonal Antibody
  1. By Value
3. Recombinant Insulin
  1. By Value
4. Vaccine
  1. By Value
5. Blood Factor
  1. By Value
6. Human Growth Hormone
  1. By Value
7. Erythropoietin
  1. By Value
8. Fusion Protein
  1. By Value
9. Recombinant Enzyme
  1. By Value
10. Interferon
  1. By Value
11. Colony-stimulating Factor
  1. By Value
12. Gene Therapy
  1. By Value
13. Cell Therapy
  1. By Value
14. Oligonucleotides
  1. By Value
15. Peptide
  1. By Value
16. Botulinum Toxin
  1. By Value
17. Others
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Branded Drugs
  1. By Value
3. Generic Drugs
  1. By Value
By Mode of Purchase
1. Introduction
  1. Mode of Purchase By Value
2. Prescription Drugs
  1. By Value
3. Over-the-counter (OTC) Drugs
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injection
  1. By Value
3. Tablets
  1. By Value
4. Others
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Parenteral
  1. By Value
3. Oral
  1. By Value
4. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals
  1. By Value
3. Specialty Clinics
  1. By Value
4. Homecare
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacy
  1. By Value
3. Retail Pharmacy
  1. By Value
4. Online Pharmacy
  1. By Value
5. Others
  1. By Value
U.S.
1. By Source
  1. Introduction
    1. Source By Value
  2. Microbial
    1. By Value
  3. Mammalian
    1. By Value
  4. Others
    1. By Value
2. By Manufacturing
  1. Introduction
    1. Manufacturing By Value
  2. In-house
    1. By Value
  3. Outsourced
    1. By Value
3. By Product
  1. Introduction
    1. Product By Value
  2. Monoclonal Antibodies
    1. By Value
  3. Vaccines
    1. By Value
  4. Recombinant Proteins
    1. By Value
  5. Antisense & RNAi Therapeutics
    1. By Value
  6. Others
    1. By Value
4. By Disease Category
  1. Introduction
    1. Disease Category By Value
  2. Oncology
    1. By Value
  3. Infectious Diseases
    1. By Value
  4. Immunological Disorders
    1. By Value
  5. Cardiovascular Disorders
    1. By Value
  6. Hematological Disorders
    1. By Value
  7. Others
    1. By Value
5. By Type
  1. Introduction
    1. Type By Value
  2. Tumor Necrosis Factor (TNF) Inhibitor
    1. By Value
  3. T-cell Inhibitor
    1. By Value
  4. Selective Co-stimulation Modulators
    1. By Value
  5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
    1. By Value
  6. Interleukin-1 (IL-1) Blocker
    1. By Value
  7. B-cell Inhibitor
    1. By Value
6. By Drug Class
  1. Introduction
    1. Drug Class By Value
  2. Monoclonal Antibody
    1. By Value
  3. Recombinant Insulin
    1. By Value
  4. Vaccine
    1. By Value
  5. Blood Factor
    1. By Value
  6. Human Growth Hormone
    1. By Value
  7. Erythropoietin
    1. By Value
  8. Fusion Protein
    1. By Value
  9. Recombinant Enzyme
    1. By Value
  10. Interferon
    1. By Value
  11. Colony-stimulating Factor
    1. By Value
  12. Gene Therapy
    1. By Value
  13. Cell Therapy
    1. By Value
  14. Oligonucleotides
    1. By Value
  15. Peptide
    1. By Value
  16. Botulinum Toxin
    1. By Value
  17. Others
    1. By Value
7. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Branded Drugs
    1. By Value
  3. Generic Drugs
    1. By Value
8. By Mode of Purchase
  1. Introduction
    1. Mode of Purchase By Value
  2. Prescription Drugs
    1. By Value
  3. Over-the-counter (OTC) Drugs
    1. By Value
9. By Dosage Form
  1. Introduction
    1. Dosage Form By Value
  2. Injection
    1. By Value
  3. Tablets
    1. By Value
  4. Others
    1. By Value
10. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Parenteral
    1. By Value
  3. Oral
    1. By Value
  4. Others
    1. By Value
11. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals
    1. By Value
  3. Specialty Clinics
    1. By Value
  4. Homecare
    1. By Value
  5. Others
    1. By Value
12. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacy
    1. By Value
  3. Retail Pharmacy
    1. By Value
  4. Online Pharmacy
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Source
1. Introduction
  1. Source By Value
2. Microbial
  1. By Value
3. Mammalian
  1. By Value
4. Others
  1. By Value
By Manufacturing
1. Introduction
  1. Manufacturing By Value
2. In-house
  1. By Value
3. Outsourced
  1. By Value
By Product
1. Introduction
  1. Product By Value
2. Monoclonal Antibodies
  1. By Value
3. Vaccines
  1. By Value
4. Recombinant Proteins
  1. By Value
5. Antisense & RNAi Therapeutics
  1. By Value
6. Others
  1. By Value
By Disease Category
1. Introduction
  1. Disease Category By Value
2. Oncology
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorders
  1. By Value
5. Cardiovascular Disorders
  1. By Value
6. Hematological Disorders
  1. By Value
7. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tumor Necrosis Factor (TNF) Inhibitor
  1. By Value
3. T-cell Inhibitor
  1. By Value
4. Selective Co-stimulation Modulators
  1. By Value
5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
  1. By Value
6. Interleukin-1 (IL-1) Blocker
  1. By Value
7. B-cell Inhibitor
  1. By Value
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Monoclonal Antibody
  1. By Value
3. Recombinant Insulin
  1. By Value
4. Vaccine
  1. By Value
5. Blood Factor
  1. By Value
6. Human Growth Hormone
  1. By Value
7. Erythropoietin
  1. By Value
8. Fusion Protein
  1. By Value
9. Recombinant Enzyme
  1. By Value
10. Interferon
  1. By Value
11. Colony-stimulating Factor
  1. By Value
12. Gene Therapy
  1. By Value
13. Cell Therapy
  1. By Value
14. Oligonucleotides
  1. By Value
15. Peptide
  1. By Value
16. Botulinum Toxin
  1. By Value
17. Others
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Branded Drugs
  1. By Value
3. Generic Drugs
  1. By Value
By Mode of Purchase
1. Introduction
  1. Mode of Purchase By Value
2. Prescription Drugs
  1. By Value
3. Over-the-counter (OTC) Drugs
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injection
  1. By Value
3. Tablets
  1. By Value
4. Others
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Parenteral
  1. By Value
3. Oral
  1. By Value
4. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals
  1. By Value
3. Specialty Clinics
  1. By Value
4. Homecare
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacy
  1. By Value
3. Retail Pharmacy
  1. By Value
4. Online Pharmacy
  1. By Value
5. Others
  1. By Value
U.K.
1. By Source
  1. Introduction
    1. Source By Value
  2. Microbial
    1. By Value
  3. Mammalian
    1. By Value
  4. Others
    1. By Value
2. By Manufacturing
  1. Introduction
    1. Manufacturing By Value
  2. In-house
    1. By Value
  3. Outsourced
    1. By Value
3. By Product
  1. Introduction
    1. Product By Value
  2. Monoclonal Antibodies
    1. By Value
  3. Vaccines
    1. By Value
  4. Recombinant Proteins
    1. By Value
  5. Antisense & RNAi Therapeutics
    1. By Value
  6. Others
    1. By Value
4. By Disease Category
  1. Introduction
    1. Disease Category By Value
  2. Oncology
    1. By Value
  3. Infectious Diseases
    1. By Value
  4. Immunological Disorders
    1. By Value
  5. Cardiovascular Disorders
    1. By Value
  6. Hematological Disorders
    1. By Value
  7. Others
    1. By Value
5. By Type
  1. Introduction
    1. Type By Value
  2. Tumor Necrosis Factor (TNF) Inhibitor
    1. By Value
  3. T-cell Inhibitor
    1. By Value
  4. Selective Co-stimulation Modulators
    1. By Value
  5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
    1. By Value
  6. Interleukin-1 (IL-1) Blocker
    1. By Value
  7. B-cell Inhibitor
    1. By Value
6. By Drug Class
  1. Introduction
    1. Drug Class By Value
  2. Monoclonal Antibody
    1. By Value
  3. Recombinant Insulin
    1. By Value
  4. Vaccine
    1. By Value
  5. Blood Factor
    1. By Value
  6. Human Growth Hormone
    1. By Value
  7. Erythropoietin
    1. By Value
  8. Fusion Protein
    1. By Value
  9. Recombinant Enzyme
    1. By Value
  10. Interferon
    1. By Value
  11. Colony-stimulating Factor
    1. By Value
  12. Gene Therapy
    1. By Value
  13. Cell Therapy
    1. By Value
  14. Oligonucleotides
    1. By Value
  15. Peptide
    1. By Value
  16. Botulinum Toxin
    1. By Value
  17. Others
    1. By Value
7. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Branded Drugs
    1. By Value
  3. Generic Drugs
    1. By Value
8. By Mode of Purchase
  1. Introduction
    1. Mode of Purchase By Value
  2. Prescription Drugs
    1. By Value
  3. Over-the-counter (OTC) Drugs
    1. By Value
9. By Dosage Form
  1. Introduction
    1. Dosage Form By Value
  2. Injection
    1. By Value
  3. Tablets
    1. By Value
  4. Others
    1. By Value
10. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Parenteral
    1. By Value
  3. Oral
    1. By Value
  4. Others
    1. By Value
11. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals
    1. By Value
  3. Specialty Clinics
    1. By Value
  4. Homecare
    1. By Value
  5. Others
    1. By Value
12. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacy
    1. By Value
  3. Retail Pharmacy
    1. By Value
  4. Online Pharmacy
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Source
1. Introduction
  1. Source By Value
2. Microbial
  1. By Value
3. Mammalian
  1. By Value
4. Others
  1. By Value
By Manufacturing
1. Introduction
  1. Manufacturing By Value
2. In-house
  1. By Value
3. Outsourced
  1. By Value
By Product
1. Introduction
  1. Product By Value
2. Monoclonal Antibodies
  1. By Value
3. Vaccines
  1. By Value
4. Recombinant Proteins
  1. By Value
5. Antisense & RNAi Therapeutics
  1. By Value
6. Others
  1. By Value
By Disease Category
1. Introduction
  1. Disease Category By Value
2. Oncology
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorders
  1. By Value
5. Cardiovascular Disorders
  1. By Value
6. Hematological Disorders
  1. By Value
7. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tumor Necrosis Factor (TNF) Inhibitor
  1. By Value
3. T-cell Inhibitor
  1. By Value
4. Selective Co-stimulation Modulators
  1. By Value
5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
  1. By Value
6. Interleukin-1 (IL-1) Blocker
  1. By Value
7. B-cell Inhibitor
  1. By Value
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Monoclonal Antibody
  1. By Value
3. Recombinant Insulin
  1. By Value
4. Vaccine
  1. By Value
5. Blood Factor
  1. By Value
6. Human Growth Hormone
  1. By Value
7. Erythropoietin
  1. By Value
8. Fusion Protein
  1. By Value
9. Recombinant Enzyme
  1. By Value
10. Interferon
  1. By Value
11. Colony-stimulating Factor
  1. By Value
12. Gene Therapy
  1. By Value
13. Cell Therapy
  1. By Value
14. Oligonucleotides
  1. By Value
15. Peptide
  1. By Value
16. Botulinum Toxin
  1. By Value
17. Others
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Branded Drugs
  1. By Value
3. Generic Drugs
  1. By Value
By Mode of Purchase
1. Introduction
  1. Mode of Purchase By Value
2. Prescription Drugs
  1. By Value
3. Over-the-counter (OTC) Drugs
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injection
  1. By Value
3. Tablets
  1. By Value
4. Others
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Parenteral
  1. By Value
3. Oral
  1. By Value
4. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals
  1. By Value
3. Specialty Clinics
  1. By Value
4. Homecare
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacy
  1. By Value
3. Retail Pharmacy
  1. By Value
4. Online Pharmacy
  1. By Value
5. Others
  1. By Value
China
1. By Source
  1. Introduction
    1. Source By Value
  2. Microbial
    1. By Value
  3. Mammalian
    1. By Value
  4. Others
    1. By Value
2. By Manufacturing
  1. Introduction
    1. Manufacturing By Value
  2. In-house
    1. By Value
  3. Outsourced
    1. By Value
3. By Product
  1. Introduction
    1. Product By Value
  2. Monoclonal Antibodies
    1. By Value
  3. Vaccines
    1. By Value
  4. Recombinant Proteins
    1. By Value
  5. Antisense & RNAi Therapeutics
    1. By Value
  6. Others
    1. By Value
4. By Disease Category
  1. Introduction
    1. Disease Category By Value
  2. Oncology
    1. By Value
  3. Infectious Diseases
    1. By Value
  4. Immunological Disorders
    1. By Value
  5. Cardiovascular Disorders
    1. By Value
  6. Hematological Disorders
    1. By Value
  7. Others
    1. By Value
5. By Type
  1. Introduction
    1. Type By Value
  2. Tumor Necrosis Factor (TNF) Inhibitor
    1. By Value
  3. T-cell Inhibitor
    1. By Value
  4. Selective Co-stimulation Modulators
    1. By Value
  5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
    1. By Value
  6. Interleukin-1 (IL-1) Blocker
    1. By Value
  7. B-cell Inhibitor
    1. By Value
6. By Drug Class
  1. Introduction
    1. Drug Class By Value
  2. Monoclonal Antibody
    1. By Value
  3. Recombinant Insulin
    1. By Value
  4. Vaccine
    1. By Value
  5. Blood Factor
    1. By Value
  6. Human Growth Hormone
    1. By Value
  7. Erythropoietin
    1. By Value
  8. Fusion Protein
    1. By Value
  9. Recombinant Enzyme
    1. By Value
  10. Interferon
    1. By Value
  11. Colony-stimulating Factor
    1. By Value
  12. Gene Therapy
    1. By Value
  13. Cell Therapy
    1. By Value
  14. Oligonucleotides
    1. By Value
  15. Peptide
    1. By Value
  16. Botulinum Toxin
    1. By Value
  17. Others
    1. By Value
7. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Branded Drugs
    1. By Value
  3. Generic Drugs
    1. By Value
8. By Mode of Purchase
  1. Introduction
    1. Mode of Purchase By Value
  2. Prescription Drugs
    1. By Value
  3. Over-the-counter (OTC) Drugs
    1. By Value
9. By Dosage Form
  1. Introduction
    1. Dosage Form By Value
  2. Injection
    1. By Value
  3. Tablets
    1. By Value
  4. Others
    1. By Value
10. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Parenteral
    1. By Value
  3. Oral
    1. By Value
  4. Others
    1. By Value
11. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals
    1. By Value
  3. Specialty Clinics
    1. By Value
  4. Homecare
    1. By Value
  5. Others
    1. By Value
12. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacy
    1. By Value
  3. Retail Pharmacy
    1. By Value
  4. Online Pharmacy
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Source
1. Introduction
  1. Source By Value
2. Microbial
  1. By Value
3. Mammalian
  1. By Value
4. Others
  1. By Value
By Manufacturing
1. Introduction
  1. Manufacturing By Value
2. In-house
  1. By Value
3. Outsourced
  1. By Value
By Product
1. Introduction
  1. Product By Value
2. Monoclonal Antibodies
  1. By Value
3. Vaccines
  1. By Value
4. Recombinant Proteins
  1. By Value
5. Antisense & RNAi Therapeutics
  1. By Value
6. Others
  1. By Value
By Disease Category
1. Introduction
  1. Disease Category By Value
2. Oncology
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorders
  1. By Value
5. Cardiovascular Disorders
  1. By Value
6. Hematological Disorders
  1. By Value
7. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tumor Necrosis Factor (TNF) Inhibitor
  1. By Value
3. T-cell Inhibitor
  1. By Value
4. Selective Co-stimulation Modulators
  1. By Value
5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
  1. By Value
6. Interleukin-1 (IL-1) Blocker
  1. By Value
7. B-cell Inhibitor
  1. By Value
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Monoclonal Antibody
  1. By Value
3. Recombinant Insulin
  1. By Value
4. Vaccine
  1. By Value
5. Blood Factor
  1. By Value
6. Human Growth Hormone
  1. By Value
7. Erythropoietin
  1. By Value
8. Fusion Protein
  1. By Value
9. Recombinant Enzyme
  1. By Value
10. Interferon
  1. By Value
11. Colony-stimulating Factor
  1. By Value
12. Gene Therapy
  1. By Value
13. Cell Therapy
  1. By Value
14. Oligonucleotides
  1. By Value
15. Peptide
  1. By Value
16. Botulinum Toxin
  1. By Value
17. Others
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Branded Drugs
  1. By Value
3. Generic Drugs
  1. By Value
By Mode of Purchase
1. Introduction
  1. Mode of Purchase By Value
2. Prescription Drugs
  1. By Value
3. Over-the-counter (OTC) Drugs
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injection
  1. By Value
3. Tablets
  1. By Value
4. Others
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Parenteral
  1. By Value
3. Oral
  1. By Value
4. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals
  1. By Value
3. Specialty Clinics
  1. By Value
4. Homecare
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacy
  1. By Value
3. Retail Pharmacy
  1. By Value
4. Online Pharmacy
  1. By Value
5. Others
  1. By Value
UAE
1. By Source
  1. Introduction
    1. Source By Value
  2. Microbial
    1. By Value
  3. Mammalian
    1. By Value
  4. Others
    1. By Value
2. By Manufacturing
  1. Introduction
    1. Manufacturing By Value
  2. In-house
    1. By Value
  3. Outsourced
    1. By Value
3. By Product
  1. Introduction
    1. Product By Value
  2. Monoclonal Antibodies
    1. By Value
  3. Vaccines
    1. By Value
  4. Recombinant Proteins
    1. By Value
  5. Antisense & RNAi Therapeutics
    1. By Value
  6. Others
    1. By Value
4. By Disease Category
  1. Introduction
    1. Disease Category By Value
  2. Oncology
    1. By Value
  3. Infectious Diseases
    1. By Value
  4. Immunological Disorders
    1. By Value
  5. Cardiovascular Disorders
    1. By Value
  6. Hematological Disorders
    1. By Value
  7. Others
    1. By Value
5. By Type
  1. Introduction
    1. Type By Value
  2. Tumor Necrosis Factor (TNF) Inhibitor
    1. By Value
  3. T-cell Inhibitor
    1. By Value
  4. Selective Co-stimulation Modulators
    1. By Value
  5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
    1. By Value
  6. Interleukin-1 (IL-1) Blocker
    1. By Value
  7. B-cell Inhibitor
    1. By Value
6. By Drug Class
  1. Introduction
    1. Drug Class By Value
  2. Monoclonal Antibody
    1. By Value
  3. Recombinant Insulin
    1. By Value
  4. Vaccine
    1. By Value
  5. Blood Factor
    1. By Value
  6. Human Growth Hormone
    1. By Value
  7. Erythropoietin
    1. By Value
  8. Fusion Protein
    1. By Value
  9. Recombinant Enzyme
    1. By Value
  10. Interferon
    1. By Value
  11. Colony-stimulating Factor
    1. By Value
  12. Gene Therapy
    1. By Value
  13. Cell Therapy
    1. By Value
  14. Oligonucleotides
    1. By Value
  15. Peptide
    1. By Value
  16. Botulinum Toxin
    1. By Value
  17. Others
    1. By Value
7. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Branded Drugs
    1. By Value
  3. Generic Drugs
    1. By Value
8. By Mode of Purchase
  1. Introduction
    1. Mode of Purchase By Value
  2. Prescription Drugs
    1. By Value
  3. Over-the-counter (OTC) Drugs
    1. By Value
9. By Dosage Form
  1. Introduction
    1. Dosage Form By Value
  2. Injection
    1. By Value
  3. Tablets
    1. By Value
  4. Others
    1. By Value
10. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Parenteral
    1. By Value
  3. Oral
    1. By Value
  4. Others
    1. By Value
11. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals
    1. By Value
  3. Specialty Clinics
    1. By Value
  4. Homecare
    1. By Value
  5. Others
    1. By Value
12. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacy
    1. By Value
  3. Retail Pharmacy
    1. By Value
  4. Online Pharmacy
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Source
1. Introduction
  1. Source By Value
2. Microbial
  1. By Value
3. Mammalian
  1. By Value
4. Others
  1. By Value
By Manufacturing
1. Introduction
  1. Manufacturing By Value
2. In-house
  1. By Value
3. Outsourced
  1. By Value
By Product
1. Introduction
  1. Product By Value
2. Monoclonal Antibodies
  1. By Value
3. Vaccines
  1. By Value
4. Recombinant Proteins
  1. By Value
5. Antisense & RNAi Therapeutics
  1. By Value
6. Others
  1. By Value
By Disease Category
1. Introduction
  1. Disease Category By Value
2. Oncology
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorders
  1. By Value
5. Cardiovascular Disorders
  1. By Value
6. Hematological Disorders
  1. By Value
7. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tumor Necrosis Factor (TNF) Inhibitor
  1. By Value
3. T-cell Inhibitor
  1. By Value
4. Selective Co-stimulation Modulators
  1. By Value
5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
  1. By Value
6. Interleukin-1 (IL-1) Blocker
  1. By Value
7. B-cell Inhibitor
  1. By Value
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Monoclonal Antibody
  1. By Value
3. Recombinant Insulin
  1. By Value
4. Vaccine
  1. By Value
5. Blood Factor
  1. By Value
6. Human Growth Hormone
  1. By Value
7. Erythropoietin
  1. By Value
8. Fusion Protein
  1. By Value
9. Recombinant Enzyme
  1. By Value
10. Interferon
  1. By Value
11. Colony-stimulating Factor
  1. By Value
12. Gene Therapy
  1. By Value
13. Cell Therapy
  1. By Value
14. Oligonucleotides
  1. By Value
15. Peptide
  1. By Value
16. Botulinum Toxin
  1. By Value
17. Others
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Branded Drugs
  1. By Value
3. Generic Drugs
  1. By Value
By Mode of Purchase
1. Introduction
  1. Mode of Purchase By Value
2. Prescription Drugs
  1. By Value
3. Over-the-counter (OTC) Drugs
  1. By Value
By Dosage Form
1. Introduction
  1. Dosage Form By Value
2. Injection
  1. By Value
3. Tablets
  1. By Value
4. Others
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Parenteral
  1. By Value
3. Oral
  1. By Value
4. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals
  1. By Value
3. Specialty Clinics
  1. By Value
4. Homecare
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacy
  1. By Value
3. Retail Pharmacy
  1. By Value
4. Online Pharmacy
  1. By Value
5. Others
  1. By Value
Brazil
1. By Source
  1. Introduction
    1. Source By Value
  2. Microbial
    1. By Value
  3. Mammalian
    1. By Value
  4. Others
    1. By Value
2. By Manufacturing
  1. Introduction
    1. Manufacturing By Value
  2. In-house
    1. By Value
  3. Outsourced
    1. By Value
3. By Product
  1. Introduction
    1. Product By Value
  2. Monoclonal Antibodies
    1. By Value
  3. Vaccines
    1. By Value
  4. Recombinant Proteins
    1. By Value
  5. Antisense & RNAi Therapeutics
    1. By Value
  6. Others
    1. By Value
4. By Disease Category
  1. Introduction
    1. Disease Category By Value
  2. Oncology
    1. By Value
  3. Infectious Diseases
    1. By Value
  4. Immunological Disorders
    1. By Value
  5. Cardiovascular Disorders
    1. By Value
  6. Hematological Disorders
    1. By Value
  7. Others
    1. By Value
5. By Type
  1. Introduction
    1. Type By Value
  2. Tumor Necrosis Factor (TNF) Inhibitor
    1. By Value
  3. T-cell Inhibitor
    1. By Value
  4. Selective Co-stimulation Modulators
    1. By Value
  5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
    1. By Value
  6. Interleukin-1 (IL-1) Blocker
    1. By Value
  7. B-cell Inhibitor
    1. By Value
6. By Drug Class
  1. Introduction
    1. Drug Class By Value
  2. Monoclonal Antibody
    1. By Value
  3. Recombinant Insulin
    1. By Value
  4. Vaccine
    1. By Value
  5. Blood Factor
    1. By Value
  6. Human Growth Hormone
    1. By Value
  7. Erythropoietin
    1. By Value
  8. Fusion Protein
    1. By Value
  9. Recombinant Enzyme
    1. By Value
  10. Interferon
    1. By Value
  11. Colony-stimulating Factor
    1. By Value
  12. Gene Therapy
    1. By Value
  13. Cell Therapy
    1. By Value
  14. Oligonucleotides
    1. By Value
  15. Peptide
    1. By Value
  16. Botulinum Toxin
    1. By Value
  17. Others
    1. By Value
7. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Branded Drugs
    1. By Value
  3. Generic Drugs
    1. By Value
8. By Mode of Purchase
  1. Introduction
    1. Mode of Purchase By Value
  2. Prescription Drugs
    1. By Value
  3. Over-the-counter (OTC) Drugs
    1. By Value
9. By Dosage Form
  1. Introduction
    1. Dosage Form By Value
  2. Injection
    1. By Value
  3. Tablets
    1. By Value
  4. Others
    1. By Value
10. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Parenteral
    1. By Value
  3. Oral
    1. By Value
  4. Others
    1. By Value
11. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals
    1. By Value
  3. Specialty Clinics
    1. By Value
  4. Homecare
    1. By Value
  5. Others
    1. By Value
12. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacy
    1. By Value
  3. Retail Pharmacy
    1. By Value
  4. Online Pharmacy
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Biologics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Bristol-Myers Squibb Company
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Merck KGaA
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Johnson & Johnson Services Inc
Hoffmann La Roche Ltd

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment